GGrantIndex
← Leaderboards

Julie Anne Bastarache

Vanderbilt University Medical Center

$14,929,100
Attributed
$19,226,289
Total exposure
11
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$19,226,289 · 10
VA$0 · 1

By mechanism

R01$4,220,275 · 2
R35$3,938,208 · 1
KL2$3,359,128 · 1
RF1$3,346,228 · 1
TL1$1,565,619 · 1
R33$1,461,247 · 1

Top collaborators

Most similar at Vanderbilt University Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Lung

Research focus

LungMolecularSepsisCellsFunctional DisorderResearch PersonnelResourcesAffectNovel TherapeuticsClinically RelevantTargeted TreatmentInjuryLeadLung InjuryAdult Respiratory Distress SyndromeInnovationAlveolarFuturePermeabilityMortalityMouse ModelAcute Respiratory FailureAmericanDesign

Grant awards (42)

Neuroinflammatory mechanisms underlying sepsis-induced cognitive dysfunction$1,240,442
RF1 · FY2025 · AG
Institutional Career Development Core$1,127,194
KL2 · FY2025 · TR · contact PI
The Sepsis ClinicAl Resource And Biorepository (SCARAB) Project$728,344
R33 · FY2025 · GM · contact PI
Applying Innovative Lung Mapping Strategies to Understand Alveolar Capillary Barrier Permeability in ARDS$702,140
R35 · FY2025 · HL · contact PI
NRSA Training Core$242,881
TL1 · FY2025 · TR · contact PI
Institutional Career Development Core$1,103,336
KL2 · FY2024 · TR · contact PI
The Sepsis ClinicAl Resource And Biorepository (SCARAB) Project$732,903
R33 · FY2024 · GM · contact PI
Applying Innovative Lung Mapping Strategies to Understand Alveolar Capillary Barrier Permeability in ARDS$688,098
R35 · FY2024 · HL · contact PI
NRSA Training Core$677,021
TL1 · FY2024 · TR · contact PI
Institutional Career Development Core$1,128,598
KL2 · FY2023 · TR · contact PI
Applying Innovative Lung Mapping Strategies to Understand Alveolar Capillary Barrier Permeability in ARDS$702,140
R35 · FY2023 · HL · contact PI
NRSA Training Core$645,717
TL1 · FY2023 · TR · contact PI
The Sepsis ClinicAl Resource And Biorepository (SCARAB) Project$228,122
R21 · FY2023 · GM · contact PI
Neuroinflammatory mechanisms underlying sepsis-induced cognitive dysfunction$165,148
RF1 · FY2023 · AG
Neuroinflammatory mechanisms underlying sepsis-induced cognitive dysfunction$1,940,638
RF1 · FY2022 · AG
Applying Innovative Lung Mapping Strategies to Understand Alveolar Capillary Barrier Permeability in ARDS$704,174
R35 · FY2022 · HL · contact PI
The Sepsis ClinicAl Resource And Biorepository (SCARAB) Project$246,372
R21 · FY2022 · GM · contact PI
Applying Innovative Lung Mapping Strategies to Understand Alveolar Capillary Barrier Permeability in ARDS$709,837
R35 · FY2021 · HL · contact PI
Potential Protective Mechanisms of Tissue Factor in Acute Lung Injury$0
I01 · FY2021 · VA · contact PI
Targeting cell-free hemoglobin in sepsis to reduce lung microvascular permeability: mechanistic and translational studies$511,205
R01 · FY2020 · HL
Applying Innovative Lung Mapping Strategies to Understand Alveolar Capillary Barrier Permeability in ARDS$431,819
R35 · FY2020 · HL · contact PI
Potential Protective Mechanisms of Tissue Factor in Acute Lung Injury$0
I01 · FY2020 · VA · contact PI
Targeting cell-free hemoglobin in sepsis to reduce lung microvascular permeability: mechanistic and translational studies$511,205
R01 · FY2019 · HL
Hemoglobin in ARDS: a novel mediator of aveolar epithelial cell dysfunction$395,000
R01 · FY2019 · HL · contact PI
Potential Protective Mechanisms of Tissue Factor in Acute Lung Injury$0
I01 · FY2019 · VA · contact PI
Targeting cell-free hemoglobin in sepsis to reduce lung microvascular permeability: mechanistic and translational studies$501,431
R01 · FY2018 · HL
Hemoglobin in ARDS: a novel mediator of aveolar epithelial cell dysfunction$395,000
R01 · FY2018 · HL · contact PI
Targeting cell-free hemoglobin in sepsis to reduce lung microvascular permeability: mechanistic and translational studies$140,254
R01 · FY2018 · HL
Potential Protective Mechanisms of Tissue Factor in Acute Lung Injury$0
I01 · FY2018 · VA · contact PI
Targeting cell-free hemoglobin in sepsis to reduce lung microvascular permeability: mechanistic and translational studies$521,120
R01 · FY2017 · HL
Hemoglobin in ARDS: a novel mediator of aveolar epithelial cell dysfunction$409,765
R01 · FY2017 · HL · contact PI
Hemoglobin in ARDS: a novel mediator of aveolar epithelial cell dysfunction$392,500
R01 · FY2016 · HL · contact PI
Hemoglobin in ARDS: a novel mediator of aveolar epithelial cell dysfunction$50,295
R01 · FY2016 · HL · contact PI
Hemoglobin in ARDS: a novel mediator of aveolar epithelial cell dysfunction$392,500
R01 · FY2015 · HL · contact PI
Free Hemoglobin Potentiates Pulmonary Vascular Dysfunction in Acute Lung Injury$115,214
R21 · FY2014 · HL · contact PI
Free Hemoglobin Potentiates Pulmonary Vascular Dysfunction in Acute Lung Injury$181
R21 · FY2014 · HL · contact PI
Tissue Factor Mediated Fibrin Deposition in Acute Lung Injury$125,739
K08 · FY2013 · HL · contact PI
Free Hemoglobin Potentiates Pulmonary Vascular Dysfunction in Acute Lung Injury$117,000
R21 · FY2013 · HL · contact PI
Tissue Factor Mediated Fibrin Deposition in Acute Lung Injury$125,739
K08 · FY2012 · HL · contact PI
Tissue Factor Mediated Fibrin Deposition in Acute Lung Injury$125,739
K08 · FY2011 · HL · contact PI
Tissue Factor Mediated Fibrin Deposition in Acute Lung Injury$125,739
K08 · FY2010 · HL · contact PI
Tissue Factor Mediated Fibrin Deposition in Acute Lung Injury$125,739
K08 · FY2009 · HL · contact PI